NewsRx

Search our medical news database

Angeion Corporation

Angeion Corporation Reports Third Quarter Results

Published in Hospital Business Week, September 14th, 2008

Angeion Corporation (NASDAQ: ANGN) reported results for its fiscal 2008 third quarter ended July 31, 2008.

For the 2008 third quarter, Angeion announced net income of $259,000, or $0.06 per diluted share, on revenues of $7.6 million. This compares to 2007 third quarter net income of $4,000, or $0.00 per diluted share, on revenues of $8.9 million. Angeion's 2008 third quarter revenues were $1.3 million lower than the prior year due to the previously announced conclusion of a customer's nonrecurring clinical trial program, as well as a general year-over-year softening of orders in the Company's domestic capital equipment business.

Angeion saw...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook